Alirocumab in Patients on a Stable Dialysis Regimen

Conditions

• Hemodialysis
• Peritoneal Dialysis
• Hypercholesterolemia
• Atherosclerotic Disease

Interventions

• DRUG: Alirocumab 150 MG/ML [Praluent]

Sponsor

Baylor Research Institute

Collaborators

• [object Object]